Article info
Electronic pages
Correspondence response
Tocilizumab in recent polymyalgia rheumatica: how can we manage the interleukin-6 blockage?
- Correspondence to Professor Valérie Devauchelle, Brest University and La Cavale Blanche Hospital—Rheumatology, BD Tanguy Prigent, Brest 29609, France; valerie.devauchelle-pensec{at}chu-brest.fr
Citation
Tocilizumab in recent polymyalgia rheumatica: how can we manage the interleukin-6 blockage?
Publication history
- Received May 11, 2016
- Accepted May 14, 2016
- First published June 6, 2016.
Online issue publication
July 08, 2016
Article Versions
- Previous version (6 June 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/